Miglitol

米格列醇

Report date: 2026/03/17 10:04:53
NME

Base Information

Drug NameMiglitol
Drug Alias Name米各尼醇PlumarolSeibuleGlysetMiglibay +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsHyperglycemiaDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryNetherlands
Original Approved Date1996/07/23
Country/TerritoryUnited StatesNetherlandsMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesSanofi-Synthelabo GmbhSanwa Kagaku Kenkyusho Co Ltd
Inactive CompaniesPharmacia & Upjohn
Active IndicationsHyperglycemiaDiabetes Mellitus, Type 2
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeA10BF02
Related LinksWikipediaDrugBankKEGG